eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2021
vol. 17
 
Share:
Share:
abstract:
Image in intervention

Long-term benefit of redo sympathetic renal denervation in a patient with resistant hypertension

Tomasz Tokarek
1, 2
,
Renata Rajtar-Salwa
1
,
Łukasz Rzeszutko
1
,
Stanisław Bartuś
1

1.
Department of Cardiology and Cardiovascular Interventions, University Hospital, Krakow, Poland
2.
Department of Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Krakow, Poland
Adv Interv Cardiol 2021; 17, 2 (64): 239–241
Online publish date: 2021/07/09
View full text Get citation
 
Sympathetic renal denervation (RDN) has been demonstrated as a potential treatment option for patients with resistant hypertension [1]. Despite discouraging results after the SYMPLICITY HTN-3 trial several techniques and catheters were introduced to the market and data confirming adequate and effective denervation are growing [1, 2]. In current guidelines invasive methods are not recommended as routine treatment of resistant hypertension [3, 4]. However, a highly selected group of patients not responding to aggressive medical treatment might benefit from this method [1–4].
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.